دورية أكاديمية
A-458 - InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma
| العنوان: | A-458 - InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma |
|---|---|
| المؤلفون: | Weber, J.S., Luke, J.J., Carlino, M.S., Khattak, M.A., Meehan, R., Brown, M., Zhang, J., Krepler, C., Duic, J.P., Long, G.V. |
| المصدر: | In EJC Skin Cancer 2024 2 Supplement 1 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 27726118 |
|---|---|
| DOI: | 10.1016/j.ejcskn.2024.100158 |